AddLife AB (OSTO:ALIF B)
kr 118.5 5.5 (4.87%) Market Cap: 14.44 Bil Enterprise Value: 19.70 Bil PE Ratio: 173.85 PB Ratio: 2.67 GF Score: 72/100

Q1 2019 AddLife AB Earnings Call Transcript

May 10, 2019 / 08:00AM GMT
Release Date Price: kr61.25 (+1.24%)
Martin Almgren;publ;CFO
AddLife AB

()-

Okay, let's start. Welcome to the [Q1] Interim Report Presentation for AddLife. My name is Martin Almgren and I am the CFO for AddLife and I will have the presentation today.

I will start short with AddLife in brief presentation and AddLife is a -- as you all probably already know, we are a leading independent player in the life science market in the Nordics, mainly Nordics and from 2019 where we will also take the step out to Europe. We provide equipment, consumables related to services, mainly to the healthcare sectors in the Nordics and also the rest of Europe. We have today 40 subsidiaries and close to 900 employees. We are divided into two business areas, Labtech and Medtech and we have sales rolling 12 months of SEK2.7 billion. And during this quarter, we have done the rights issue of SEK500 million and I will come back to that a little bit later.

As I said, we are a Nordic player. To start with, Nordic is our home market and has been our home market for quite some years now. And the Nordic market has a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot